Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04060225 · ClinicalTrials.gov registry record · NA
Effects of High Caffeine Content Coffee on Blood Pressure in Young Adults
A NA study, sponsored by University of Rochester.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT04060225: Clinical Trial NA study, sponsored by University of Rochester.
NCT04060225 is a NA study that was terminated before completion, run by University of Rochester. The registered enrollment target is 1 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04060225, a NA study, was terminated before completion, sponsored by University of Rochester.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
The purpose of this study is to help further the understanding of the effects of commercially available high-caffeine containing coffee on blood pressure in healthy adult subjects.
Primary Outcome
Participants will wear a ambulatory blood pressure cuff for 24 hours with half hourly measurements of systolic and diastolic blood pressure. Mean change will be measured comparing the same participants blood pressure at 0-3 hour after drinking the coffee versus 0-3 hours after the end of the washout period.
Interventions
- OTHER Coffee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2019-12-02 |
| Est. Completion | 2019-12-19 |
| Phase | NA |
Why NCT04060225 stopped before completion
NCT04060225 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Coffee is the first listed.
NCT04060225 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04060225 about?
NCT04060225 is a clinical study titled "Effects of High Caffeine Content Coffee on Blood Pressure in Young Adults". The purpose of this study is to help further the understanding of the effects of commercially available high-caffeine containing coffee on blood pressure in healthy adult subjects.
What is the current status of trial NCT04060225?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2019-12-02. Estimated completion is 2019-12-19.
What interventions are being tested in trial NCT04060225?
The interventions under investigation include: Coffee (OTHER).
Who is sponsoring clinical trial NCT04060225?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04060225's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI